Tag: equity
-
Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.
-
Infographic – Top Tech Acquisition Timeline
The world’s five leading technology enterprises are acquiring more companies and with more money in recent years than before.
-
Immunotherapy Biotech Gains $325M in Venture Funds
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round.
-
Stem Cell Start-Up Raises $250M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing.
-
Two Biotechs Each Issue $300M+ IPOs
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions.
-
A.I. Chip Start-Up Raises $23M in Early Funds
A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams.
-
Company Launches Attacking Cancer Proteins, Lands $67M
A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies.
-
Liquid Biopsy Screening Start-Up Launches, Gains $110M
A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University.
-
Viral Disease Biotech Joins ElevateBio, Gains $120M
A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies.
-
Start-Up to Use Stem Cells for Hearing Loss
A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss.